Is anyone wonder what would required from Sientra to re-open production in a new manufacturing facility? Sec. 814.39 PMA supplements. (a) After FDA’s approval of a PMA, an applicant shall submit a PMA supplement for review and approval by FDA before making a change affecting the safety or effectiveness of the device for which the […]